Indien hält den BioNTech-Impfstoff im Moment nicht für zulassungsfähig...
https://cdsco.gov.in/opencms/resourc...03.02.2021.pdf
"The committee noted that incidents of palsy, anaphylaxis and other SAE*s have been reported during post marketing an the causality of the events with the vaccine is being investigated. Further, the firm has not proposed any plan to generate safety and immunogenicity data in Indian population. After detailed deliberation, the committee has not recommended for grant of permission for emergency use in the country at this stage"
Und die Effizienz ist möglicherweise weit weg von den genannten 95%
https://blogs.bmj.com/bmj/2021/01/04...-the-raw-data/
und die Klarstellung
https://blogs.bmj.com/bmj/2021/01/04...-the-raw-data/
"A rough estimate of vaccine efficacy against developing covid-19 symptoms, with or without a positive PCR test result, would be a relative risk reduction of 19% (see footnote)*far below the 50% effectiveness threshold for authorization set by regulators. Even after removing cases occurring within 7 days of vaccination (409 on Pfizer*s vaccine vs. 287 on placebo), which should include the majority of symptoms due to short-term vaccine reactogenicity, vaccine efficacy remains low: 29% (see footnote)."